“…MITF has emerged as a key regulator of proliferation, differentiation, cell cycle, and survival of melanocytes and melanoma cells (reviewed in Goding & Arnheiter, 2019). It also affects mast cells, retinal pigment epithelium (RPE) and osteoclast development and in addition plays a role in olfaction as well as in circadian regulation of gene expression (Atacho et al, 2020; Malcov‐Brog et al., 2018; Morii et al., 1996; Shibahara et al., 2000; Weilbaecher et al., 2001). In humans, MITF mutations have been linked to Tietz syndrome (Amiel, Watkin, Tassabehji, Read, & Winter, 1998; Smith, Kelley, Kenyon, & Hoover, 2000), Waardenburg syndrome type 2A (Tassabehji, Newton, & Read, 1994) as well as the more serious COMMAD syndrome observed in individuals carrying MITF mutations on each of the two chromosomes (George et al., 2016).…”